Cite
HARVARD Citation
Wu, Y. et al. (2020). Efficacy and safety of regorafenib as beyond second-line therapy in patients with metastatic colorectal cancer: an adjusted indirect meta-analysis and systematic review. Therapeutic advances in medical oncology. p. . [Online].